Liposomes containing Distamycin A (DA) may be clinically useful in the treatment of ocular HSV infections, especially in acyclovir-resistant HSV keratitis. This study evaluated the in vitro and in vivo performance of a topical controlled release liposomal formulation containing DA (DA-Lipo) aimed at reducing the toxicity of the encapsulated active agent and improving drug uptake by ocular tissues. The bioavailability of DA in the tear fluid and the DA uptake into the cornea were increased after instillation of DA-Lipo in rabbits, reaching the DA corneal concentration corresponding to IC50 values against HSV without any sign of transcorneal permeation of drug. DA-Lipo was definitely less cytotoxic then plain DA in rabbit corneal epithelial cells. These results provide new insights into the correlation between the in vitro data and the drug kinetics following ocular applications of liposomal vesicles

Liposomes as a potential ocular delivery system of distamycin A

CHETONI, PATRIZIA
Primo
;
MONTI, DANIELA
Secondo
;
TAMPUCCI, SILVIA;CECCHERINI-NELLI, LUCA;BURGALASSI, SUSI
Ultimo
2015-01-01

Abstract

Liposomes containing Distamycin A (DA) may be clinically useful in the treatment of ocular HSV infections, especially in acyclovir-resistant HSV keratitis. This study evaluated the in vitro and in vivo performance of a topical controlled release liposomal formulation containing DA (DA-Lipo) aimed at reducing the toxicity of the encapsulated active agent and improving drug uptake by ocular tissues. The bioavailability of DA in the tear fluid and the DA uptake into the cornea were increased after instillation of DA-Lipo in rabbits, reaching the DA corneal concentration corresponding to IC50 values against HSV without any sign of transcorneal permeation of drug. DA-Lipo was definitely less cytotoxic then plain DA in rabbit corneal epithelial cells. These results provide new insights into the correlation between the in vitro data and the drug kinetics following ocular applications of liposomal vesicles
2015
Chetoni, Patrizia; Monti, Daniela; Tampucci, Silvia; Matteoli, Barbara; CECCHERINI-NELLI, Luca; Subissi, Alessando; Burgalassi, Susi
File in questo prodotto:
File Dimensione Formato  
Dystamycin-1-s2.0-S0378517315004743-main.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 557.83 kB
Formato Adobe PDF
557.83 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Distamycin A - 1-s2.0-S0378517315004743-main.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 433.63 kB
Formato Adobe PDF
433.63 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/766531
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 36
social impact